About Synchron
Synchron develops brain-computer interface (BCI) technology that enables individuals, particularly those with severe paralysis, to control digital devices using their thoughts. Their main product involves a minimally invasive endovascular procedure for implanting the BCI, which is similar to placing stents and avoids the need for open brain surgery. This approach makes the technology safer and more accessible for a wider range of patients. Unlike competitors, Synchron focuses on providing a solution that enhances patient autonomy and social connection through direct control of computers and other devices. The company's goal is to empower patients with neurological conditions by improving their quality of life through advanced medical technology.